The latest news, trends, analysis, interviews and podcasts from the global food and beverage industry

Danish industrial biotech company EvodiaBio has raised €6 million (DKK 45 million) in a new funding round to accelerate expansion across European, North American and Asian markets, as well as to broaden applications of its fermentation-based aroma technology within the beverage sector.

The round was led by US-based RA Capital Management’s Planetary Health Fund, with participation from new investors Wild Radicals and Francis Family Funds, alongside existing backers. This brings EvodiaBio’s total capital raised to DKK 150 million over the past three years.

Founded to develop sustainable aroma molecules via fermentation, EvodiaBio has moved from lab-scale research to industrial production in just three years. The company produces yeast-derived natural monoterpenes – key volatile aroma compounds – using a platform it says is significantly more resource efficient than traditional extraction or chemical synthesis.

EvodiaBio’s initial focus has been on the beer industry, where its technology is positioned as an alternative or supplement to hops to tackle crop issues due to climate volatility.

According to the company, the platform allows brewers to achieve a consistent aroma profile while reducing dependence on agricultural inputs and supply chain risks.

EvodiaBio’s CEO Camilla Kloss Fenneberg said: “Within just three and a half years, we have gone from a research project to industrial production with all necessary approvals and a profitable product. This investment allows us to accelerate global growth and build the foundation for expansion into new markets.”

Kyle Teamey, managing partner at RA Capital, added: “The technology convincingly solves the challenge of producing natural aromas efficiently and sustainably at an industrial scale”.

While brewing remains the primary commercial focus, EvodiaBio plans to expand its technology into adjacent categories, including other beverages, wine and the wider aroma and flavour industry. Asia has been identified as a priority growth region following expansion in Europe, the US and Canada.

“Our ambition is to become a global leader in industrial biotech,” Fenneberg commented. “We see significant opportunities to apply our platform across multiple industries with a strong need for sustainable, scalable aroma solutions.”